As per NPPA Order S.O. 5690(E) dated 17 October 2026, the trade margin on 137 non-scheduled anti-cancer medicines is capped at 30%. Hetero’s revised MRPs take effect on 9 November 2026.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
The VOLGA Division of Hetero Healthcare focuses on providing therapeutic solutions across cardiovascular and metabolic healthcare, supporting the management of chronic and lifestyle-related health conditions.
Its portfolio addresses key areas such as hypertension, dyslipidaemia, diabetes, cardiovascular risk management, and associated metabolic disorders, supporting comprehensive and long-term patient care.
Backed by Hetero Healthcare’s commitment to quality, accessibility, and patient-centric care, VOLGA strives to provide dependable therapeutic solutions that support effective disease management and better patient outcomes.
View by-